Sort
16,179 grants matching “malaria”
Attenuation of Liquid Formulation for PfSPZ Vaccine by X-Ray
$300,000Eric R James · Sanaria, Inc. · R43 · FY2022 · AI
RECOMBINANT MALARIA INVASION LIGAND PROTEIN VACCINE
$300,000Entremed, Inc. · R43 · FY2001 · AI
VLVs as platform for nucleic acid-based delivery:Combining therapeutic vaccine with shRNA-mediated PD-L1 blockade for the treatment of chronic hepatitis B virus
$300,000Valerian Nakaar · Carogen Corporation · R43 · FY2020 · AI
Multicolor Photoacoustic Malaria Detector
$300,000James Suen · Cytoastra, Llc · R41 · FY2019 · AI
Development of a multimeric CD40 ligand vaccine adjuvant
$300,000Richard Syd Kornbluth · Multimeric Biotherapeutics, Inc. · R43 · FY2013 · AI
A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage.
$300,000Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2020 · AI
High Throughput Assay to Identify New Drugs Against Vivax Malaria Liver Stages
$300,000Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2012 · AI
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics
$300,000Xiaowu Liang · Immport Therapeutics, Inc. · R43 · FY2012 · AI
Process Development on a Schistosomiasis Vaccine, SchistoShield???
$300,000Darrick Albert Carter · Pai Life Sciences, Inc. · R43 · FY2014 · AI
Enhancement of gametocytogenesis in Plasmodium falciparum by genetic engineering for improved PfSPZ Vaccine Manufacture
$300,000Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2020 · AI
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2009 · AI
Development of a novel test for the early detection of Dengue Virus infection
$300,000Emily Ann Stein · Sevident, Inc. · R43 · FY2014 · AI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites (PvSPZ Challenge) for controlled human malaria infection (CHMI)
$300,000Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2017 · AI
BIOETHICS TRAINING FOR DEVELOPING COUNTRY PROFESSIONALS/
$300,000Johns Hopkins University · R25 · FY2001 · TW
Synthetic nanocapsule malaria vaccines
$300,000Thomas J Powell · Artificial Cell Technologies, Inc. · R43 · FY2011 · AI
Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Malawi
$300,000Don P Mathanga · University Of Malawi · U01 · FY2020 · GH
Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2008 · AI
Development of Monoclonal Antibody-mediated Interventions to Combat Malaria
$300,000Wenda Gao · Antagen Pharmaceuticals, Inc. · N43 · FY2022 · AI
Adenovirus Vectors for Respiratory Syncytial Virus Vaccination
$300,000Jason Graham Gall · Genvec, Inc. · R43 · FY2009 · AI
RNA Detection as an Improved Diagnostic Assay for Human Leptospirosis
$300,000Michel Ledizet · L2 Diagnostics, Llc · R41 · FY2014 · AI
Process Development on a Schistosomiasis Vaccine, SchistoShield???
$300,000Darrick Albert Carter · Pai Life Sciences, Inc. · R43 · FY2013 · AI
Multi-stage multi-antigen Vaccine for interrupting Malaria Transmission
$300,000B. Kim Lee Sim · Protein Potential, Llc · R43 · FY2012 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$299,999Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2014 · AI
A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products.
$299,999Peter F. Billingsley · Sanaria, Inc. · R43 · FY2018 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$299,999Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2015 · AI